Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds

TUESDAY, Aug. 11, 2026 — Sally Osmer jumped at the chance to be treated with the cutting-edge Alzheimer’s drug lecanemab.
Osmer has a family history of the disease, and was diagnosed with early-stage Alzheimer’s at age 74. She...